These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prolonged thrombocytopenia after administration of granulocyte colony-stimulating factor and leukapheresis in a donor for allogeneic peripheral blood stem cell transplantation. Okamoto S; Ishida A; Wakui M; Tanosaki R; Oda A; Ikeda Y Bone Marrow Transplant; 1996 Aug; 18(2):482-3. PubMed ID: 8864472 [No Abstract] [Full Text] [Related]
3. Mobilization of peripheral blood progenitor cells for allogeneic transplantation. Teshima A; Harada M Cytokines Cell Mol Ther; 1997 Jun; 3(2):101-14. PubMed ID: 9287249 [TBL] [Abstract][Full Text] [Related]
4. Allogeneic marrow reconstitution using peripheral blood stem cells: the dawn of a new era. Lane TA Transfusion; 1996 Jul; 36(7):585-9. PubMed ID: 8701452 [No Abstract] [Full Text] [Related]
5. [Collection of hematopoietic progenitor cells from healthy donors]. Bojanić I; Cepulić BG; Mazić S Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352 [TBL] [Abstract][Full Text] [Related]
6. Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors. Stroncek DF; Clay ME; Smith J; Ilstrup S; Oldham F; McCullough J Transfusion; 1996 Jul; 36(7):596-600. PubMed ID: 8701454 [TBL] [Abstract][Full Text] [Related]
7. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Anderlini P; Przepiorka D; Seong D; Miller P; Sundberg J; Lichtiger B; Norfleet F; Chan KW; Champlin R; Körbling M Transfusion; 1996 Jul; 36(7):590-5. PubMed ID: 8701453 [TBL] [Abstract][Full Text] [Related]
8. Allogeneic peripheral blood progenitor cells: current status and future directions. Dreger P; Glass B; Uharek L; Schmitz N J Hematother; 1996 Aug; 5(4):331-7. PubMed ID: 8877708 [TBL] [Abstract][Full Text] [Related]
9. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Becker PS; Wagle M; Matous S; Swanson RS; Pihan G; Lowry PA; Stewart FM; Heard SO Biol Blood Marrow Transplant; 1997 Apr; 3(1):45-9. PubMed ID: 9209740 [TBL] [Abstract][Full Text] [Related]
10. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Dreger P; Haferlach T; Eckstein V; Jacobs S; Suttorp M; Löffler H; Müller-Ruchholtz W; Schmitz N Br J Haematol; 1994 Jul; 87(3):609-13. PubMed ID: 7527648 [TBL] [Abstract][Full Text] [Related]
11. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts. Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255 [TBL] [Abstract][Full Text] [Related]
12. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472 [TBL] [Abstract][Full Text] [Related]
13. Granulocyte colony-stimulating factor administration and peripheral blood progenitor cells collection in normal donors: analysis of leukapheresis-related side effects. Martínez C; Urbano-Ispizua A; Mazzara R; Rozman C; Montserrat E Blood; 1996 Jun; 87(11):4916-7. PubMed ID: 8639872 [No Abstract] [Full Text] [Related]
14. rhG-CSF in healthy donors: mobilization of peripheral hemopoietic progenitors and effect on peripheral blood leukocytes. Sica S; Rutella S; Di Mario A; Salutari P; Rumi C; Ortu la Barbera E; Etuk B; Menichella G; D'Onofrio G; Leone G J Hematother; 1996 Aug; 5(4):391-7. PubMed ID: 8877714 [TBL] [Abstract][Full Text] [Related]
15. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Stroncek DF; Clay ME; Petzoldt ML; Smith J; Jaszcz W; Oldham FB; McCullough J Transfusion; 1996 Jul; 36(7):601-10. PubMed ID: 8701455 [TBL] [Abstract][Full Text] [Related]
16. Peripheral blood stem cells from unrelated donors for allogeneic transplantation. Russell NH; Warwick RM; Goldman J Transplantation; 1999 Jan; 67(2):339. PubMed ID: 10075606 [No Abstract] [Full Text] [Related]
17. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts. Adkins D; Spitzer G; Johnston M; Velasquez W; Dunphy F; Petruska P Transfusion; 1997 Jul; 37(7):737-48. PubMed ID: 9225939 [TBL] [Abstract][Full Text] [Related]